GLP-1s like Ozempic and Zepbound have been hailed as a miracle cure for weight loss, but they couldn’t erase the trauma that ...

Michelle Obama’s new photoshoot showing a slimmer look sparked online speculation about her using Ozempic. The diabetes drug, often linked to weight loss, is not FDA-approved for slimming. There’s no ...

A pill version of semaglutide, the ingredient in Ozempic and Wegovy, did not slow the progress of Alzheimer's disease, drugmaker Novo Nordisk announced on Nov. 24.

Health officials have repeatedly warned Britons against buying the jabs on social media and to be aware of scam online ...

While Eli Lilly stock has surged beyond a $1 trillion market capitalization, Novo Nordisk is having difficulty keeping up, both in growth and pipeline progression.

About valuation, the current forward P/E is 13, but that number only looks cheap because earnings are at an unsustainably ...

Shares in Novo Nordisk, the Danish maker of Ozempic and Wegovy, tumbled after studies showed the active ingredient in its hit ...

An Alzheimer drug had never represented more than 5% of Novo’s share price, the Kepler analysts said. As a result, any cuts ...

Overindulging in rich foods while taking a drug like Wegovy or Zepbound can raise the risk of side effects like nausea and ...

Novo Nordisk’s stock is experiencing a steep drop following major clinical setbacks and intensifying competitive pressure in ...

An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression ...